Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia, Blood, vol.98, issue.12, pp.3249-3255, 2001. ,
DOI : 10.1182/blood.V98.12.3249
Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia, European Journal of Haematology, vol.36, issue.4, pp.189-193, 2002. ,
DOI : 10.1034/j.1600-0609.2001.066005324.x
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders, Haematologica, vol.88, pp.1123-1129, 2003. ,
Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients, British Journal of Haematology, vol.106, issue.1, pp.42-48, 2005. ,
DOI : 10.1111/j.1365-2141.2004.05280.x
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, issue.20, pp.2391-2405, 2016. ,
DOI : 10.1182/blood-2016-03-643544
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms, New England Journal of Medicine, vol.369, issue.25, pp.2379-2390, 2013. ,
DOI : 10.1056/NEJMoa1311347
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms, Leukemia, vol.9, issue.7, pp.1407-1413, 2014. ,
DOI : 10.1038/leu.2014.35
A standardized endogenous megakaryocytic erythroid colony assay for the diagnosis of essential thrombocythemia, Haematologica, vol.89, pp.1207-1212, 2004. ,
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis, Blood, vol.124, issue.7, pp.1062-1069, 2014. ,
DOI : 10.1182/blood-2014-05-578435
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis, Blood, vol.124, issue.16, pp.2507-2513, 2014. ,
DOI : 10.1182/blood-2014-05-579136
, and Vascular Endothelial Growth Factor Receptor 2???Positive Endothelial Progenitor Cells in Myelofibrosis With Myeloid Metaplasia, Journal of Clinical Oncology, vol.23, issue.24, pp.5688-5695, 2005. ,
DOI : 10.1200/JCO.2005.09.021
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms, Leukemia, vol.90, issue.2, pp.431-438, 2016. ,
DOI : 10.1038/leu.2014.270